Janux Therapeutics Inc
JANXHealthcare|Biotechnology|USA
$16.41
-0.35 (-2.09%)
DCF (FCF)
$5.59
Tangible Book
$15.47
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (47)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Doyle Janeen Noel | Chief Corp. & Bus. Dev. Ofcr | 2026-06-02 | SELL | 4,059 | $14.03 | $56.9K |
| Dobek Maria | Vice President, Accounting | 2026-05-11 | SELL | 2,038 | $14.17 | $28.9K |
| Meyer Andrew Hollman | Chief Business Officer | 2026-01-02 | SELL | 1,879 | $13.73 | $25.8K |
| DiRaimondo Thomas | Chief Scientific Officer | 2026-01-02 | SELL | 2,505 | $13.73 | $34.4K |
| Campbell David Alan | President and CEO | 2026-01-02 | SELL | 8,072 | $13.73 | $110.8K |
| Winter Charles M. | Chief Technical Officer | 2026-01-02 | SELL | 2,401 | $13.73 | $33K |
| McIver Zachariah | Chief Medical Officer | 2026-01-02 | SELL | 2,714 | $13.73 | $37.3K |
| Dobek Maria | Vice President, Accounting | 2026-01-02 | SELL | 1,462 | $13.73 | $20.1K |
| Meyer Andrew Hollman | Chief Business Officer | 2025-12-01 | SELL | 3,333 | $32.98 | $109.9K |
| Meyer Andrew Hollman | Chief Business Officer | 2025-11-14 | SELL | 3,333 | $30 | $100K |
| Meyer Andrew Hollman | Chief Business Officer | 2025-10-28 | SELL | 16,665 | $30.06 | $500.9K |
| Meyer Andrew Hollman | Chief Business Officer | 2025-05-01 | SELL | 3,333 | $32.03 | $106.8K |
| Meyer Andrew Hollman | Chief Business Officer | 2025-04-21 | SELL | 3,334 | $30 | $100K |
| RA Capital Healthcare Fund LP | Director, 10% Owner | 2025-03-07 | BUY | 824,041 | $30.75 | $25339.3K |
| Meyer Andrew Hollman | Chief Business Officer | 2025-03-03 | SELL | 3,334 | $32.15 | $107.2K |
| Meyer Andrew Hollman | Chief Business Officer | 2025-02-03 | SELL | 3,334 | $42.29 | $141K |
| Campbell David Alan | President and CEO | 2025-01-07 | SELL | 5,000 | $60 | $300K |
| Meyer Andrew Hollman | Chief Business Officer | 2025-01-02 | SELL | 13,334 | $54.88 | $731.8K |
| Campbell David Alan | President and CEO | 2024-12-24 | SELL | 25,000 | $56.19 | $1404.8K |
| Campbell David Alan | President and CEO | 2024-12-03 | SELL | 15,000 | $67 | $1005K |
| Campbell David Alan | President and CEO | 2024-11-25 | SELL | 25,000 | $51.6 | $1290K |
| Campbell David Alan | President and CEO | 2024-10-28 | SELL | 25,000 | $53.54 | $1338.5K |
| RA Capital Healthcare Fund LP | Director, 10% Owner | 2024-10-18 | BUY | 1,200,000 | $44.75 | $53700K |
| Avalon Ventures XI, L.P. | 10% Owner | 2024-10-18 | SELL | 1,673,128 | $46.3 | $77465.8K |
| Avalon Ventures XI, L.P. | 10% Owner | 2024-09-30 | SELL | 307,779 | $46.96 | $14453.3K |
| Meyer Andrew Hollman | Chief Business Officer | 2024-09-27 | SELL | 50,000 | $45.96 | $2298K |
| DiRaimondo Thomas | Chief Scientific Officer | 2024-09-27 | SELL | 5,000 | $46.34 | $231.7K |
| Campbell David Alan | President and CEO | 2024-09-27 | SELL | 25,000 | $46.31 | $1157.8K |
| Lichter Jay | 10% Owner | 2024-09-13 | SELL | 3,815 | $46.68 | $178.1K |
| Avalon Ventures XI, L.P. | 10% Owner | 2024-09-12 | SELL | 451,091 | $46.89 | $21151.7K |
| Avalon Ventures XI, L.P. | 10% Owner | 2024-09-09 | SELL | 242,182 | $42 | $10171.6K |
| Lichter Jay | Director, 10% Owner | 2024-06-03 | SELL | 1,500,000 | $54.75 | $82125K |
| Reardon Tighe | Acting CFO | 2024-06-03 | SELL | 822,721 | $54.75 | $45044K |
| Avalon Ventures XI, L.P. | 10% Owner | 2024-06-03 | SELL | 1,500,000 | $54.75 | $82125K |
| Avalon Ventures XI, L.P. | 10% Owner | 2023-11-13 | BUY | 849,854 | $5.87 | $4988.6K |
| Reardon Tighe | Acting CFO, 10% Owner | 2023-11-13 | BUY | 849,854 | $5.87 | $4988.6K |
| Lichter Jay | Director, 10% Owner | 2023-11-13 | BUY | 849,854 | $5.87 | $4988.6K |
| RA Capital Healthcare Fund LP | Director, 10% Owner | 2023-07-19 | BUY | 495,008 | $12.46 | $6167.8K |
| ORBIMED ADVISORS LLC | Director | 2021-12-29 | SELL | 40,400 | $20.3 | $820.1K |
| Thompson Peter A. | Director | 2021-12-29 | SELL | 40,400 | $20.3 | $820.1K |
| ORBIMED ADVISORS LLC | Director | 2021-12-21 | SELL | 119,400 | $19 | $2268.6K |
| Thompson Peter A. | Director | 2021-12-21 | SELL | 119,400 | $19 | $2268.6K |
| ORBIMED ADVISORS LLC | Director | 2021-12-16 | SELL | 393,300 | $19.07 | $7500.2K |
| Thompson Peter A. | Director | 2021-12-16 | SELL | 393,300 | $19.07 | $7500.2K |
| Bregua Corp | 10% Owner | 2021-06-15 | BUY | 58,823 | $17 | $1000K |
| Thompson Peter A. | Director | 2021-06-15 | BUY | 705,853 | $17 | $11999.5K |
| ORBIMED ADVISORS LLC | Director | 2021-06-15 | BUY | 705,853 | $17 | $11999.5K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked